Maurizio Villanti

HACOR score to predict NIV failure in patients with COVID-related hypoxemic respiratory failure managed in the ordinary ward and in the critical care setting

Francesco Pepe, Ginevra Fabiani, Carolina Cogozzo, Valerio Mazzilli et autres

it (code pays fourni par la source)

4C mortality score and COVID-19 mortality risk score: an analysis in four different age groups of an Italian population

Lorenzo Pelagatti, Ginevra Fabiani, Anna De Paris, Alessia Lagomarsini et autres

it (code pays fourni par la source)

Clinical characteristics of patients hospitalized for COVID-19: comparison between different age groups

Ginevra Fabiani, Carolina Cogozzo, Anna De Paris, Valentina Di Maria et autres

Abstract Background To test whether known prognosticators of COVID-19 maintained their stratification ability across age groups. Methods We performed a retrospective study. We included all patients (n = 2225), who presented to the Emergency Department of the Careggi University Hospital for COVID-19 …

it (code pays fourni par la source)

Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis

Marco Allinovi, Giorgio Trivioli, Gianmarco Lugli, Maurizio Villanti et autres

The B-cell-depleting antibody rituximab is frequently used in patients with minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS), but there are no predictors of response [1]. These are particularly needed in adult patients, given the substantial incidence of ‘secondary’ forms in …

it (code pays fourni par la source)